Analyst Ranking
Top 16%
#821 out of 5346 analysts
Average Return
+21.53%
Win Rate
66%23 out of 35
Risk vs Reward
Poor
Good

Jason N. Butler's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Precigen IncPGEN
+124.53%$3.22$7.23
2025-08-19 -
2026-08-07
Buy
Gh Research PLCGHRS
+90.02%$15.93$30.27
2026-03-06 -
2026-08-07
Buy
Precigen IncPGEN
+85.86%$3.89$7.23
2026-03-26 -
2026-08-07
Buy
Abivax SaABVX
+80.59%$72.50$130.93
2026-06-02 -
2026-08-07
Buy
Rapport Therapeutics IncRAPP
+77.28%$25.66$45.49
2025-11-07 -
2026-08-07
Buy

Jason N. Butler Analyst Color

Get additional color on Jason N. Butler's coverage of popular stocks

Jason N. Butler's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Halozyme Therapeutics IncHALO
1Buy$93.00-9.81%Maintains
a day ago
Cytokinetics IncCYTK
2Buy$110.00+43.30%Maintains
a day ago
Zevra Therapeutics IncZVRA
2Buy$28.00+142.21%Maintains
2 days ago
Acadia Pharmaceuticals IncACAD
4Buy$36.00+23.25%Maintains
3 days ago
Leonabio IncLONA
1Buy$18.00+134.38%Upgrades
9 days ago
Argenx SeARGX
2Buy$932.00+7.74%Maintains
15 days ago
Abivax SaABVX
4Buy$187.00+42.82%Reiterates
a month ago
Rezolute IncRZLT
2Buy$11.00+134.54%Upgrades
2 months ago
Gh Research PLCGHRS
2Buy$39.00+28.84%Maintains
3 months ago
Precigen IncPGEN
3Buy$11.00+52.14%Maintains
3 months ago
Avalo Therapeutics IncAVTX
2Buy$55.00+200.22%Maintains
3 months ago
Prothena Corp Public Ltd CoPRTA
1Buy$20.00+128.31%Maintains
3 months ago
Cormedix IncCRMD
2Buy$19.00+155.38%Reiterates
3 months ago
Minerva Neurosciences IncNERV
1Buy$14.00+227.87%Initiates Coverage On
4 months ago
Nasus Pharma LtdNSRX
1Buy$18.00+420.98%Maintains
4 months ago
Esperion Therapeutics IncESPR
1Buy$5.00+57.23%Maintains
5 months ago
Ironwood Pharmaceuticals IncIRWD
1Buy$10.00+131.48%Maintains
5 months ago
Achieve Life Sciences IncACHV
1Buy$19.00+185.71%Initiates Coverage On
8 months ago
Rapport Therapeutics IncRAPP
1Buy$80.00+75.86%Maintains
9 months ago
Terawulf IncWULF
1Buy$22.00+28.81%Maintains
9 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.